Literature DB >> 31486727

Expanding Access to Home-Based Palliative Care: A Randomized Controlled Trial Protocol.

Susan Enguidanos1, Anna Rahman1, Torrie Fields2, Wendy Mack3, Richard Brumley4, Michael Rabow5, Melissa Mert1,3.   

Abstract

Introduction: Studies show that home-based palliative care (HBPC) improves participant outcomes and satisfaction with care while also decreasing hospitalizations and emergency department visits. U.S. health care payment reforms create financial opportunities to offer HBPC. Consequently, more HBPC programs are emerging, heightening the need to evaluate their effectiveness.
Methods: This randomized, controlled trial is comparing the effectiveness of an evidence-based model of HBPC and enhanced usual primary care for participants who receive primary care from medical groups and clinics organized under an accountable care organization or Medicare Advantage plan. Palliative care services are reimbursed by our partnering health plan provider. The five-year trial will enroll 1155 seriously ill participants (and ∼884 of their caregivers) with heart failure, chronic obstructive pulmonary disease, or advanced cancer. We are collecting data via telephone surveys with participants at baseline and one and two months postenrollment and with caregivers at baseline, one and two months postenrollments, and following the death of a loved one. We are collecting participant-reported outcome measures of pain, symptoms, anxiety, depression, participant-provider communication, and hope. Caregiver outcome measures include caregiver burden, communication with providers, anxiety, and depression. Additional outcomes are participant survival time and participants' emergency department visits and hospitalizations. Study Implementation: Challenges and Contributions: Our research team has encountered several significant challenges in early study implementation. These include engaging primary care providers in the study and coordinating logistics with a health plan. Both challenges have contributed to a lag in participant enrollment. Despite these challenges, our study holds tremendous promise to accelerate adoption and spread of an evidence-based HBPC model across the country.

Entities:  

Keywords:  home-based palliative care; primary care physician; primary palliative care; randomized controlled trial

Mesh:

Year:  2019        PMID: 31486727     DOI: 10.1089/jpm.2019.0147

Source DB:  PubMed          Journal:  J Palliat Med        ISSN: 1557-7740            Impact factor:   2.947


  4 in total

1.  Frontline provider perceptions of implementing home-based palliative care covered by an insurer.

Authors:  Alexis Coulourides Kogan; Oscar Li; Torrie Fields; Laura Mosqueda; Karl Lorenz
Journal:  Health Serv Res       Date:  2021-12-22       Impact factor: 3.734

2.  Reluctance to Accept Palliative Care and Recommendations for Improvement: Findings From Semi-Structured Interviews With Patients and Caregivers.

Authors:  Valeria Cardenas; Anna Rahman; Yujun Zhu; Susan Enguidanos
Journal:  Am J Hosp Palliat Care       Date:  2021-04-26       Impact factor: 2.500

3.  Patient and physician perspectives on engaging in palliative and healthcare trials: a qualitative descriptive study.

Authors:  Valeria Cardenas; Anna Rahman; Jenna Giulioni; Alexis Coulourides Kogan; Susan Enguidanos
Journal:  BMC Palliat Care       Date:  2021-10-14       Impact factor: 3.234

4.  Hospital at home: home-based end-of-life care.

Authors:  Sasha Shepperd; Daniela C Gonçalves-Bradley; Sharon E Straus; Bee Wee
Journal:  Cochrane Database Syst Rev       Date:  2021-03-16
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.